HC Wainwright Issues Pessimistic Estimate for VNDA Earnings
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) – Analysts at HC Wainwright lowered their Q2 2025 earnings estimates for Vanda Pharmaceuticals in a report released on Wednesday, May 14th. HC Wainwright analyst R. Selvaraju now expects that the biopharmaceutical company will earn ($0.35) per share for the quarter, down from their prior forecast of ($0.19). […]
Vanda Pharmaceuticals Inc. (NASDAQ:VNDA – Free Report) – Analysts at HC Wainwright lowered their Q2 2025 earnings estimates for Vanda Pharmaceuticals in a report released on Wednesday, May 14th. HC Wainwright analyst R. Selvaraju now expects that the biopharmaceutical company will earn ($0.35) per share for the quarter, down from their prior forecast of ($0.19). […]
